Topographic EEG changes with benzodiazepine administration in generalized anxiety disorder

The regional cerebral effects of an anxiolytic (clorazepate) in 20 patients with generalized anxiety disorder were assessed using 16-channel electroencephalogram (EEG) power spectral estimate maps of the left hemisphere. Patients were studied with double-blind random assignment to placebo or drug an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biological psychiatry (1969) 1985-01, Vol.20 (8), p.832,IN1,837-836,IN2,842
Hauptverfasser: Buchsbaum, Monte S., Hazlett, Erin, Sicotte, Nancy, Stein, Marsha, Wu, Joe, Zetin, Mark
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 836,IN2,842
container_issue 8
container_start_page 832,IN1,837
container_title Biological psychiatry (1969)
container_volume 20
creator Buchsbaum, Monte S.
Hazlett, Erin
Sicotte, Nancy
Stein, Marsha
Wu, Joe
Zetin, Mark
description The regional cerebral effects of an anxiolytic (clorazepate) in 20 patients with generalized anxiety disorder were assessed using 16-channel electroencephalogram (EEG) power spectral estimate maps of the left hemisphere. Patients were studied with double-blind random assignment to placebo or drug and were assessed at baseline, day 7, and day 14 with EEG and Hamilton Anxiety Ratings. Ten age- and sex-matched normal controls were also tested. Hamilton Anxiety Ratings were decreased significantly more in the drug group than in the placebo group. Topographic maps of EEG activity revealed decreases in occipital alpha and parietal delta, together with increases in posterior frontal (central EEG leads) and parietal beta. Decreases in delta are consistent with a lack of sedation; the reciprocal beta increases in parietal cortex are similarly consistent. This pattern of regional EEG changes in the direction of alert attentiveness, together with individual differences, observed in frontal/parietal and occipital alpha activity, suggests the importance of at least these two cortical regions for anxiolytic action. Differences between patients with generalized anxiety disorder and normals were restricted to the occipital and temporal regions. These results suggest the importance of multilead recording in assessing EEG correlates of drug action.
doi_str_mv 10.1016/0006-3223(85)90208-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76259402</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0006322385902082</els_id><sourcerecordid>76259402</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-1667e562f211b399ce3a54050c5c884edd7801cc7b25dd8dc127d2272a3c5d9f3</originalsourceid><addsrcrecordid>eNp9kMFu1DAQhi1EVZbCG4DkA0LlELAnceJcKqFqKZUq9VIuXCyvPdkdlLWDnQW6T9-EXe2xp9Fovv_X6GPsnRSfpZD1FyFEXZQA5aVWn1oBQhfwgi2kbsoCKgEv2eKEvGKvc_41rQ2APGfnoGtooVqwnw9xiOtkhw05vlzecLexYY2Z_6Vxw1cY9tGT3eNAAbn1WwqUx2RHioFT4GsMmGxPe_Tchn-E4yP3lGPymN6ws872Gd8e5wX78W35cP29uLu_ub3-ele4SqqxkHXdoKqhAylXZds6LK2qhBJOOa0r9L7RQjrXrEB5r72T0HiABmzplG-78oJ9PPQOKf7eYR7NlrLDvrcB4y6bpgbVTj4msDqALsWcE3ZmSLS16dFIYWalZvZlZl9GK_NfqZlj74_9u9UW_Sl0dDjdPxzvNjvbd8kGR_mEadXKFuaaqwOGk4s_hMlkRxgcekroRuMjPf_HE13DkrY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76259402</pqid></control><display><type>article</type><title>Topographic EEG changes with benzodiazepine administration in generalized anxiety disorder</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Buchsbaum, Monte S. ; Hazlett, Erin ; Sicotte, Nancy ; Stein, Marsha ; Wu, Joe ; Zetin, Mark</creator><creatorcontrib>Buchsbaum, Monte S. ; Hazlett, Erin ; Sicotte, Nancy ; Stein, Marsha ; Wu, Joe ; Zetin, Mark</creatorcontrib><description>The regional cerebral effects of an anxiolytic (clorazepate) in 20 patients with generalized anxiety disorder were assessed using 16-channel electroencephalogram (EEG) power spectral estimate maps of the left hemisphere. Patients were studied with double-blind random assignment to placebo or drug and were assessed at baseline, day 7, and day 14 with EEG and Hamilton Anxiety Ratings. Ten age- and sex-matched normal controls were also tested. Hamilton Anxiety Ratings were decreased significantly more in the drug group than in the placebo group. Topographic maps of EEG activity revealed decreases in occipital alpha and parietal delta, together with increases in posterior frontal (central EEG leads) and parietal beta. Decreases in delta are consistent with a lack of sedation; the reciprocal beta increases in parietal cortex are similarly consistent. This pattern of regional EEG changes in the direction of alert attentiveness, together with individual differences, observed in frontal/parietal and occipital alpha activity, suggests the importance of at least these two cortical regions for anxiolytic action. Differences between patients with generalized anxiety disorder and normals were restricted to the occipital and temporal regions. These results suggest the importance of multilead recording in assessing EEG correlates of drug action.</description><identifier>ISSN: 0006-3223</identifier><identifier>EISSN: 1873-2402</identifier><identifier>DOI: 10.1016/0006-3223(85)90208-2</identifier><identifier>PMID: 2862924</identifier><identifier>CODEN: BIPCBF</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Anti-Anxiety Agents - therapeutic use ; Anxiety Disorders - drug therapy ; Anxiety Disorders - physiopathology ; Biological and medical sciences ; Clorazepate Dipotassium - therapeutic use ; Electroencephalography ; Female ; Humans ; Individuality ; Male ; Medical sciences ; Middle Aged ; Miscellaneous ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Techniques and methods</subject><ispartof>Biological psychiatry (1969), 1985-01, Vol.20 (8), p.832,IN1,837-836,IN2,842</ispartof><rights>1985</rights><rights>1986 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-1667e562f211b399ce3a54050c5c884edd7801cc7b25dd8dc127d2272a3c5d9f3</citedby><cites>FETCH-LOGICAL-c415t-1667e562f211b399ce3a54050c5c884edd7801cc7b25dd8dc127d2272a3c5d9f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0006-3223(85)90208-2$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8591922$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2862924$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Buchsbaum, Monte S.</creatorcontrib><creatorcontrib>Hazlett, Erin</creatorcontrib><creatorcontrib>Sicotte, Nancy</creatorcontrib><creatorcontrib>Stein, Marsha</creatorcontrib><creatorcontrib>Wu, Joe</creatorcontrib><creatorcontrib>Zetin, Mark</creatorcontrib><title>Topographic EEG changes with benzodiazepine administration in generalized anxiety disorder</title><title>Biological psychiatry (1969)</title><addtitle>Biol Psychiatry</addtitle><description>The regional cerebral effects of an anxiolytic (clorazepate) in 20 patients with generalized anxiety disorder were assessed using 16-channel electroencephalogram (EEG) power spectral estimate maps of the left hemisphere. Patients were studied with double-blind random assignment to placebo or drug and were assessed at baseline, day 7, and day 14 with EEG and Hamilton Anxiety Ratings. Ten age- and sex-matched normal controls were also tested. Hamilton Anxiety Ratings were decreased significantly more in the drug group than in the placebo group. Topographic maps of EEG activity revealed decreases in occipital alpha and parietal delta, together with increases in posterior frontal (central EEG leads) and parietal beta. Decreases in delta are consistent with a lack of sedation; the reciprocal beta increases in parietal cortex are similarly consistent. This pattern of regional EEG changes in the direction of alert attentiveness, together with individual differences, observed in frontal/parietal and occipital alpha activity, suggests the importance of at least these two cortical regions for anxiolytic action. Differences between patients with generalized anxiety disorder and normals were restricted to the occipital and temporal regions. These results suggest the importance of multilead recording in assessing EEG correlates of drug action.</description><subject>Adult</subject><subject>Anti-Anxiety Agents - therapeutic use</subject><subject>Anxiety Disorders - drug therapy</subject><subject>Anxiety Disorders - physiopathology</subject><subject>Biological and medical sciences</subject><subject>Clorazepate Dipotassium - therapeutic use</subject><subject>Electroencephalography</subject><subject>Female</subject><subject>Humans</subject><subject>Individuality</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Miscellaneous</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Techniques and methods</subject><issn>0006-3223</issn><issn>1873-2402</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1985</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFu1DAQhi1EVZbCG4DkA0LlELAnceJcKqFqKZUq9VIuXCyvPdkdlLWDnQW6T9-EXe2xp9Fovv_X6GPsnRSfpZD1FyFEXZQA5aVWn1oBQhfwgi2kbsoCKgEv2eKEvGKvc_41rQ2APGfnoGtooVqwnw9xiOtkhw05vlzecLexYY2Z_6Vxw1cY9tGT3eNAAbn1WwqUx2RHioFT4GsMmGxPe_Tchn-E4yP3lGPymN6ws872Gd8e5wX78W35cP29uLu_ub3-ele4SqqxkHXdoKqhAylXZds6LK2qhBJOOa0r9L7RQjrXrEB5r72T0HiABmzplG-78oJ9PPQOKf7eYR7NlrLDvrcB4y6bpgbVTj4msDqALsWcE3ZmSLS16dFIYWalZvZlZl9GK_NfqZlj74_9u9UW_Sl0dDjdPxzvNjvbd8kGR_mEadXKFuaaqwOGk4s_hMlkRxgcekroRuMjPf_HE13DkrY</recordid><startdate>19850101</startdate><enddate>19850101</enddate><creator>Buchsbaum, Monte S.</creator><creator>Hazlett, Erin</creator><creator>Sicotte, Nancy</creator><creator>Stein, Marsha</creator><creator>Wu, Joe</creator><creator>Zetin, Mark</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19850101</creationdate><title>Topographic EEG changes with benzodiazepine administration in generalized anxiety disorder</title><author>Buchsbaum, Monte S. ; Hazlett, Erin ; Sicotte, Nancy ; Stein, Marsha ; Wu, Joe ; Zetin, Mark</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-1667e562f211b399ce3a54050c5c884edd7801cc7b25dd8dc127d2272a3c5d9f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1985</creationdate><topic>Adult</topic><topic>Anti-Anxiety Agents - therapeutic use</topic><topic>Anxiety Disorders - drug therapy</topic><topic>Anxiety Disorders - physiopathology</topic><topic>Biological and medical sciences</topic><topic>Clorazepate Dipotassium - therapeutic use</topic><topic>Electroencephalography</topic><topic>Female</topic><topic>Humans</topic><topic>Individuality</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Miscellaneous</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Techniques and methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Buchsbaum, Monte S.</creatorcontrib><creatorcontrib>Hazlett, Erin</creatorcontrib><creatorcontrib>Sicotte, Nancy</creatorcontrib><creatorcontrib>Stein, Marsha</creatorcontrib><creatorcontrib>Wu, Joe</creatorcontrib><creatorcontrib>Zetin, Mark</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biological psychiatry (1969)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Buchsbaum, Monte S.</au><au>Hazlett, Erin</au><au>Sicotte, Nancy</au><au>Stein, Marsha</au><au>Wu, Joe</au><au>Zetin, Mark</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Topographic EEG changes with benzodiazepine administration in generalized anxiety disorder</atitle><jtitle>Biological psychiatry (1969)</jtitle><addtitle>Biol Psychiatry</addtitle><date>1985-01-01</date><risdate>1985</risdate><volume>20</volume><issue>8</issue><spage>832,IN1,837</spage><epage>836,IN2,842</epage><pages>832,IN1,837-836,IN2,842</pages><issn>0006-3223</issn><eissn>1873-2402</eissn><coden>BIPCBF</coden><abstract>The regional cerebral effects of an anxiolytic (clorazepate) in 20 patients with generalized anxiety disorder were assessed using 16-channel electroencephalogram (EEG) power spectral estimate maps of the left hemisphere. Patients were studied with double-blind random assignment to placebo or drug and were assessed at baseline, day 7, and day 14 with EEG and Hamilton Anxiety Ratings. Ten age- and sex-matched normal controls were also tested. Hamilton Anxiety Ratings were decreased significantly more in the drug group than in the placebo group. Topographic maps of EEG activity revealed decreases in occipital alpha and parietal delta, together with increases in posterior frontal (central EEG leads) and parietal beta. Decreases in delta are consistent with a lack of sedation; the reciprocal beta increases in parietal cortex are similarly consistent. This pattern of regional EEG changes in the direction of alert attentiveness, together with individual differences, observed in frontal/parietal and occipital alpha activity, suggests the importance of at least these two cortical regions for anxiolytic action. Differences between patients with generalized anxiety disorder and normals were restricted to the occipital and temporal regions. These results suggest the importance of multilead recording in assessing EEG correlates of drug action.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>2862924</pmid><doi>10.1016/0006-3223(85)90208-2</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-3223
ispartof Biological psychiatry (1969), 1985-01, Vol.20 (8), p.832,IN1,837-836,IN2,842
issn 0006-3223
1873-2402
language eng
recordid cdi_proquest_miscellaneous_76259402
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adult
Anti-Anxiety Agents - therapeutic use
Anxiety Disorders - drug therapy
Anxiety Disorders - physiopathology
Biological and medical sciences
Clorazepate Dipotassium - therapeutic use
Electroencephalography
Female
Humans
Individuality
Male
Medical sciences
Middle Aged
Miscellaneous
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Techniques and methods
title Topographic EEG changes with benzodiazepine administration in generalized anxiety disorder
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T20%3A18%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Topographic%20EEG%20changes%20with%20benzodiazepine%20administration%20in%20generalized%20anxiety%20disorder&rft.jtitle=Biological%20psychiatry%20(1969)&rft.au=Buchsbaum,%20Monte%20S.&rft.date=1985-01-01&rft.volume=20&rft.issue=8&rft.spage=832,IN1,837&rft.epage=836,IN2,842&rft.pages=832,IN1,837-836,IN2,842&rft.issn=0006-3223&rft.eissn=1873-2402&rft.coden=BIPCBF&rft_id=info:doi/10.1016/0006-3223(85)90208-2&rft_dat=%3Cproquest_cross%3E76259402%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76259402&rft_id=info:pmid/2862924&rft_els_id=0006322385902082&rfr_iscdi=true